The global market for kidney stone management devices is projected to nearly double from USD 2.8 billion in 2023 to USD 5.1 billion by 2033, signaling a major healthcare investment opportunity, according to Coherent Market Insights. The market's projected near-doubling signals a period of strong growth in the kidney stone management device market. Patients requiring treatment for kidney stones will benefit from advanced technologies as the industry evolves to meet rising demand.

But the market is clearly growing rapidly, yet different analyses present significantly varied compound annual growth rates, indicating a lack of consensus on the precise pace of expansion. Technavio forecasts a 4.5% CAGR between 2023 and 2028, significantly lower than the 9.1% projected by Coherent Market Insights.

Companies and investors should carefully evaluate the underlying assumptions of market forecasts to accurately gauge investment risks and opportunities in this expanding medical device sector.

  • The global kidney stone management devices market size is estimated to be valued at USD 2.8 billion in 2023.
  • The market is expected to reach USD 5.1 billion by 2033, according to Coherent Market Insights.
  • A compound annual growth rate (CAGR) of 9.1% from 2023 to 2033 is projected by Coherent Market Insights.
  • Ureteroscopy procedures have success rates reaching up to 95%, according to Technavio (data from 2023-2028 forecast period).
  • The shift toward single-use devices has been particularly prominent in hospitals across North America and Asia Pacific by late 2023 and Asia Pacific by late 2025, notes Coherent Market Insights.
  • The ESWL device segment maintains dominance with 36% industry share, according to Coherent Market Insights (data from 2023-2033 forecast period).
  • Asia is estimated to contribute 34% to the growth of the global market during the forecast period, according to Technavio.

Procedural Advancements Drive Market Evolution

Ureteroscopy procedures boast success rates reaching up to 95%, positioning them as a highly effective treatment option for kidney stones. The high efficacy of ureteroscopy procedures drives increased adoption of advanced devices within the market. The shift toward single-use devices has been particularly prominent in hospitals across North America and Asia Pacific by late 2025, indicating a preference for sterile, efficient tools.